Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Asset Utilization Ratio (2016 - 2025)

Ocular Therapeutix (OCUL) has 12 years of Asset Utilization Ratio data on record, last reported at 0.09 in Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 36.57% year-over-year to 0.09; the TTM value through Dec 2025 reached 0.09, down 36.57%, while the annual FY2025 figure was 0.08, 54.28% down from the prior year.
  • Asset Utilization Ratio reached 0.09 in Q4 2025 per OCUL's latest filing, down from 0.13 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.43 in Q2 2023 and bottomed at 0.09 in Q4 2025.
  • Average Asset Utilization Ratio over 5 years is 0.21, with a median of 0.16 recorded in 2021.
  • Peak YoY movement for Asset Utilization Ratio: skyrocketed 186.88% in 2022, then crashed 73.39% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.21 in 2021, then skyrocketed by 62.42% to 0.33 in 2022, then dropped by 15.69% to 0.28 in 2023, then tumbled by 52.35% to 0.13 in 2024, then tumbled by 36.57% to 0.09 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.09 in Q4 2025, 0.13 in Q3 2025, and 0.13 in Q2 2025.